Anti-CD3/CD28-Teff stimulation did not affect CXCR4 frequency (Supplementary Fig. S3a) and R54 did not affect Teff proliferation (Supplementary Fig. S3b) in both RCC- and HD-samples. The gene discussed is CD28; the disease is renal cell carcinoma.